Loading...

Sanofi

SNW.DEXETRA
Healthcare
Drug Manufacturers - General
81.13
0.09(0.11%)
German Market opens in 7h 48m

Sanofi (SNW.DE) Stock Competitors & Peer Comparison

See (SNW.DE) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - General Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
SNW.DE€80.18-0.34%96.5B19.90€4.03+4.89%
LLY.DE€799.60-2.19%755.5B40.16€19.91+0.67%
JNJ.DE€204.10-1.61%491.6B21.58€9.46+2.18%
4AB.DE€179.00-1.08%316.5B87.32€2.05+3.19%
6MK.DE€103.80-0.92%256.6B16.63€6.24+2.74%
ZEG.DE€160.70+0.59%249.2B28.49€5.64+1.69%
AMG.DE€300.25+0.74%161.9B24.37€12.32+2.75%
GIS.DE€119.68-1.22%148.5B20.63€5.80+2.29%
PFE.DE€23.03-1.52%131B19.85€1.16+6.37%
PFE.F€22.92-1.99%130.3B19.76€1.16+6.41%
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

SNW.DE vs LLY.DE Comparison April 2026

SNW.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SNW.DE stands at 96.5B. In comparison, LLY.DE has a market cap of 755.5B. Regarding current trading prices, SNW.DE is priced at €80.18, while LLY.DE trades at €799.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SNW.DE currently has a P/E ratio of 19.90, whereas LLY.DE's P/E ratio is 40.16. In terms of profitability, SNW.DE's ROE is +0.15%, compared to LLY.DE's ROE of +0.98%. Regarding short-term risk, SNW.DE is less volatile compared to LLY.DE. This indicates potentially lower risk in terms of short-term price fluctuations for SNW.DE.Check LLY.DE's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions